1RFX
| Crystal Structure of resisitin | Descriptor: | ACETATE ION, CHLORIDE ION, DI(HYDROXYETHYL)ETHER, ... | Authors: | Patel, S.D, Rajala, M.W, Scherer, P.E, Shapiro, L, Burley, S.K, New York SGX Research Center for Structural Genomics (NYSGXRC) | Deposit date: | 2003-11-10 | Release date: | 2004-06-08 | Last modified: | 2021-02-03 | Method: | X-RAY DIFFRACTION (2.002 Å) | Cite: | Disulfide-dependent multimeric assembly of resistin family hormones Science, 304, 2004
|
|
4OCS
| Crystal structure of human Fab CAP256-VRC26.10, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | CAP256-VRC26.10 heavy chain, CAP256-VRC26.10 light chain | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-01-09 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (1.901 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
4OCW
| Crystal structure of human Fab CAP256-VRC26.06, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | CAP256-VRC26.06 heavy chain, CAP256-VRC26.06 light chain | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-01-09 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (3.001 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
4OD1
| Crystal structure of human Fab CAP256-VRC26.03, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | CAP256-VRC26.03 heavy chain, CAP256-VRC26.03 light chain | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-01-09 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (2.69 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
4OCR
| Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | CAP256-VRC26.01 heavy chain, CAP256-VRC26.01 light chain | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-01-09 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (1.895 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
4ODH
| Crystal structure of human Fab CAP256-VRC26.UCA, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | CAP256-VRC26.UCA heavy chain, CAP256-VRC26.UCA light chain | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-01-10 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (2.894 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
4OD3
| Crystal structure of human Fab CAP256-VRC26.07, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, CAP256-VRC26.07 heavy chain, CAP256-VRC26.07 light chain, ... | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-01-09 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (2.616 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
4ORG
| Crystal structure of human Fab CAP256-VRC26.04, a potent V1V2-directed HIV-1 neutralizing antibody | Descriptor: | CAP256-VRC26.04 heavy chain, CAP256-VRC26.04 light chain | Authors: | Gorman, J, Doria-Rose, N.A, Schramm, C.A, Moore, P.L, Mascola, J.R, Shapiro, L, Morris, L, Kwong, P.D. | Deposit date: | 2014-02-11 | Release date: | 2014-02-26 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (3.121 Å) | Cite: | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature, 509, 2014
|
|
7L5B
| |
7KS9
| |
7LS9
| |
7LSS
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Fab 2-7 variable heavy chain, ... | Authors: | Rapp, M, Shapiro, L. | Deposit date: | 2021-02-18 | Release date: | 2021-03-17 | Last modified: | 2021-09-29 | Method: | ELECTRON MICROSCOPY (3.72 Å) | Cite: | Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure, 29, 2021
|
|
1Q7E
| Crystal Structure of YfdW protein from E. coli | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, Hypothetical protein yfdW, METHIONINE | Authors: | Gogos, A, Gorman, J, Shapiro, L, Burley, S.K, New York SGX Research Center for Structural Genomics (NYSGXRC) | Deposit date: | 2003-08-18 | Release date: | 2003-09-30 | Last modified: | 2021-02-03 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Structure of Escherichia coli YfdW, a type III CoA transferase. Acta Crystallogr.,Sect.D, 60, 2004
|
|
1PQY
| Crystal structure of formyl-coA transferase yfdW from E. coli | Descriptor: | Hypothetical protein yfdW | Authors: | Gogos, A, Gorman, J, Shapiro, L, Burley, S.K, New York SGX Research Center for Structural Genomics (NYSGXRC) | Deposit date: | 2003-06-19 | Release date: | 2003-09-30 | Last modified: | 2021-02-03 | Method: | X-RAY DIFFRACTION (2.35 Å) | Cite: | Structure of Escherichia coli YfdW, a type III CoA transferase. Acta Crystallogr.,Sect.D, 60, 2004
|
|
1R3D
| |
1Q6Y
| Hypothetical protein YfdW from E. coli bound to Coenzyme A | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, COENZYME A, Hypothetical protein yfdW | Authors: | Gogos, A, Gorman, J, Shapiro, L, Burley, S.K, New York SGX Research Center for Structural Genomics (NYSGXRC) | Deposit date: | 2003-08-14 | Release date: | 2003-09-30 | Last modified: | 2023-08-16 | Method: | X-RAY DIFFRACTION (1.99 Å) | Cite: | Structure of Escherichia coli YfdW, a type III CoA transferase. Acta Crystallogr.,Sect.D, 60, 2004
|
|
1PQW
| |
1S31
| Crystal Structure Analysis of the human Tub protein (isoform a) spanning residues 289 through 561 | Descriptor: | TRIETHYLENE GLYCOL, tubby isoform a | Authors: | Boutboul, S, Carroll, K.J, Basdevant, A, Gomez, C, Nandrot, E, Clement, K, Shapiro, L, Abitbol, M. | Deposit date: | 2004-01-12 | Release date: | 2005-01-25 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2.704 Å) | Cite: | A novel human obesity and sensory deficit syndrome resulting from a mutation in the TUB gene To be Published
|
|
1S80
| Structure of Serine Acetyltransferase from Haemophilis influenzae Rd | Descriptor: | Serine acetyltransferase | Authors: | Gorman, J, Gogos, A, Shapiro, L, Burley, S.K, New York SGX Research Center for Structural Genomics (NYSGXRC) | Deposit date: | 2004-01-30 | Release date: | 2004-08-31 | Last modified: | 2021-02-03 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Structure of serine acetyltransferase from Haemophilus influenzae Rd. Acta Crystallogr.,Sect.D, 60, 2004
|
|
1TT7
| |
1TVL
| |
1TO3
| |
1TSJ
| |
1T5J
| |
1U6L
| |